Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial.
Sakamoto E, Ishida W, Sumi T, Kishimoto T, Tada K, Fukuda K, Yoneda T, Kuroiwa H, Terao E, Fujisawa Y, Nakakura S, Jian K, Okumichi H, Kiuchi Y, Fukushima A.
Sakamoto E, et al. Among authors: yoneda t.
Sci Rep. 2019 Mar 6;9(1):3755. doi: 10.1038/s41598-019-40255-9.
Sci Rep. 2019.
PMID: 30842572
Free PMC article.
Clinical Trial.